Viewing Study NCT01276405


Ignite Creation Date: 2025-12-25 @ 3:11 AM
Ignite Modification Date: 2026-05-29 @ 8:13 PM
Study NCT ID: NCT01276405
Status: TERMINATED
Last Update Posted: 2016-11-02
First Post: 2011-01-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Observational Study of Xeloda (Capecitabine) Monotherapy in Patients With Colorectal Cancer (AXEL)
Sponsor: Hoffmann-La Roche
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colorectal Cancer View
Keywords: